Doug Emhoff, Kamala Harris’s husband, takes a leave of absence from his law firm.;8;17
Here’s the business news to watch this week.;7;27
U.S. corporations say they’ll hire one million Black workers in the next decade.;12;10
A look at Douglas Emhoff’s legal career as he seeks to become the nation’s first Second Gentleman.;9;8
Find Your Place in the Vaccine Line;12;3
How Big Pharma Grew Addicted to Big Profits;3;12
U.S. Issues Sanctions on Russian Center Involved in Potentially Deadly Cyberattacks;10;23
Congo’s Deadliest Ebola Outbreak Is Declared Over;6;25
Should Musicians Be Allowed to Copy or Borrow From Other Artists?;1;7
Encuentra tu lugar en la fila de vacunación;12;10
Federal Study of Covid Treatments Enters a New Phase;8;18
(Let Us Out of This Clause);7;6
U.S. and Allies Blame Russia for Cyberattack on Republic of Georgia;2;20
Big Pharma May Pose an Obstacle to Vaccine Development;3;2
Covid-19 Vaccines Are Chance at Salvation, Financial and Beyond, for Drug Makers;10;13
Madeleine Albright on Covid-19, Fascism and Her Dream Superhero Team;7;29
Health Care Costs Are Rising. Fund Returns Are Less Reliable.;1;17
Covid-19 Changed How the World Does Science, Together;4;1
Elon Musk and Mark Zuckerberg Aren’t on the Same Page;4;30
The Loans and the Fury;4;27
Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s End;7;22
Coronavirus, Texas, Paycheck Protection Program: Your Tuesday Briefing;4;28
Mark Zuckerberg’s Biggest Challenge Yet;6;2
The Swiss Cheese Model of Pandemic Defense;12;5
U.S. Charges Russian Intelligence Officers in Major Cyberattacks;10;19
It’s Got a Great Beat, and You Can File a Lawsuit to It;1;6
U.K.-Hong Kong, U.S. Protests, Travel: Your Thursday Briefing;6;4
The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.;11;17
Congo Was Close to Defeating Ebola. Then One More Case Emerged.;4;11
TikTok, Trump and an Impulse to Act as C.E.O. to Corporate America;8;3
A Call to Arms: Under Attack, Pro-Vaccine Doctors Fight Back;3;10
Why Dunkin’ Is Worth Nearly $9 Billion;10;26
Will Doug Emhoff’s Legal Career Be an Issue for the Biden-Harris Ticket?;9;8
Grim Economic Outlook Grips Markets as Stocks Plummet;3;16
Should C.E.O.s Keep Speaking Out?;11;9
If You’re Pregnant and Working, Know Your Rights;4;18
Cuomo Calls Subway Cars Filled With Homeless People ‘Disgusting’;4;28
Airbnb’s Stunning I.P.O.;12;11
The New World of Work;7;27
How the F.D.A. Stood Up to the President;10;20
America’s Economy Begins to Shut Down as Pandemic Measures Take Hold;3;16
When the Story Line Is This Easy, You Just Know;9;4
How Upbeat Vaccine News Fueled a Stock Surge, and an Uproar;5;23
Stocks Rise on Hopes for Economic Recovery;5;26
This Isn’t Just JPMorgan’s Problem;9;16
She Was Pregnant With Twins During Covid. Why Did Only One Survive?;8;6
How ACT UP Remade Political Organizing in America;4;13
Scandal Dogs AstraZeneca’s Vaccine Partner in China;12;7
Blunders Eroded U.S. Confidence in Early Vaccine Front-Runner;12;8
How Long Will a Vaccine Really Take?;4;30
More U.S. Coronavirus Cases Emerge, as China’s Death Toll Rises;1;26
Profits and Pride at Stake, the Race for a Vaccine Intensifies;5;2
How Scientists Could Stop the Next Pandemic Before It Starts;4;21
The Coronavirus in America: The Year Ahead;4;18
Scientists Link Covid-19 Risk to Genetic Variations;6;3
Drugmaker Pauses Covid-19 Vaccine Trial for Safety Review;9;8
Coronavirus Drug and Treatment Tracker;7;16
Faces of Power: 80% Are White, Even as U.S. Becomes More Diverse;9;10
Can a Vaccine for Covid-19 Be Developed in Record Time?;6;9
Does Palantir See Too Much?;10;21
Vaccine Development: The Ebola Example;3;4
